BBruno Sarmento is Principal Investigator and Group Leader at Institute for Research and Innovation in Health (i3S), University of Porto (UP), and Invited Associate Professor at Instituto Universitário de Ciências da Saúde (IUCS), Portugal. His research is focused on the development of mucosal tissue engineering models to validate functionalized nanomedicines and to perform in vitro/in vivo correlation. He has also established functionalized nanomedicines for mucosal drug delivery of drug with poor mucosal bioavailability. He published more than 400 papers in international journals, most in top journals (20000 Scopus citations; H-index 73). He edited 5 books, participated in more than 50 invited/selected talks in national and international meetings and was awarded several distinctions. He has supervised/co-supervised 15 Post-Docs, 50 PhD students and 40 MSc students. He is editor of European Journal of Pharmaceutical Sciences, and member of the Editorial Advisory Board of several international journals, including the Journal of Controlled Release, Expert Opinion on Drug Delivery and Pharmaceutics. Bruno Sarmento was the first Chair of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society (CRS) and is now Director-at-Large of CRS and member of CRS College of Fellows. José das Neves is a Post-Doctoral Researcher at INEB, the Instituto de Engenharia Biomédica, Porto, Portugal. His research interests focuses on vaginal drug delivery, nanotechnology-based drug carriers and biomaterials. He has previously written 7 book chapters and is the co-editor of three books.

• Introduction: From the "magic bullet" to advanced nanomaterials: An historical perspective Part I. Ligand selection and functionalization of nanomaterials1. Phage display technology for screening antibody fragments2. Bioengineered approaches for site-orientation of peptide-based ligands of nanomaterials3. Engineered protein variants for bioconjugation4. Engineering of nanozymes for biomedical applications5. Strategies for the functionalization of mesoporous nanomaterials for biomedical use6. Systematic evolution of ligands by exponential enrichment (SELEX) for aptamer selection7. Biological methodologies for assessment of functionality of nanomaterialsPart II. Specific applications of functionalized nanomaterials in therapy and diagnostics8. Functionalized graphene-based materials for bioimaging applications9. Multifunctional magnetic nanoparticles for theranostic applications10. Stimuli-sensitive grafting polymers for targeted anticancer drug delivery 11. Functional moieties for intracellular traffic of nanomaterials12. Biofunctionalized mesoporous silica nanomaterials for nuclei targeting13. Lipid-derived nanoparticles for targeted delivery of siRNA14. Aptamer-siRNA nanoparticles for targeted anti-HIV therapeutics15. Peptide and protein self-assembled nanofibers for vaccine development and immunotherapy16. Functional biomaterials for vascular tissue engineering17. Functionalized hydrogels for culture and delivery of cellsPart III. Manufacturing, regulatory challenges and clinical testing of functionalized nanomaterial-based products18. Manufacturing and safety guidelines for the manufactured functional nanomaterials19. Challenges for planning clinical trials of functionalized nanomaterials20. Clinical testing of ACCURINS® therapeutics: challenges and lessons learned

BBruno Sarmento is Principal Investigator and Group Leader at Institute for Research and Innovation in Health (i3S), University of Porto (UP), and Invited Associate Professor at Instituto Universitário de Ciências da Saúde (IUCS), Portugal. His research is focused on the development of mucosal tissue engineering models to validate functionalized nanomedicines and to perform in vitro/in vivo correlation. He has also established functionalized nanomedicines for mucosal drug delivery of drug with poor mucosal bioavailability. He published more than 400 papers in international journals, most in top journals (20000 Scopus citations; H-index 73). He edited 5 books, participated in more than 50 invited/selected talks in national and international meetings and was awarded several distinctions. He has supervised/co-supervised 15 Post-Docs, 50 PhD students and 40 MSc students. He is editor of European Journal of Pharmaceutical Sciences, and member of the Editorial Advisory Board of several international journals, including the Journal of Controlled Release, Expert Opinion on Drug Delivery and Pharmaceutics. Bruno Sarmento was the first Chair of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society (CRS) and is now Director-at-Large of CRS and member of CRS College of Fellows. José das Neves is a Post-Doctoral Researcher at INEB, the Instituto de Engenharia Biomédica, Porto, Portugal. His research interests focuses on vaginal drug delivery, nanotechnology-based drug carriers and biomaterials. He has previously written 7 book chapters and is the co-editor of three books.

• Introduction: From the "magic bullet" to advanced nanomaterials: An historical perspective Part I. Ligand selection and functionalization of nanomaterials1. Phage display technology for screening antibody fragments2. Bioengineered approaches for site-orientation of peptide-based ligands of nanomaterials3. Engineered protein variants for bioconjugation4. Engineering of nanozymes for biomedical applications5. Strategies for the functionalization of mesoporous nanomaterials for biomedical use6. Systematic evolution of ligands by exponential enrichment (SELEX) for aptamer selection7. Biological methodologies for assessment of functionality of nanomaterialsPart II. Specific applications of functionalized nanomaterials in therapy and diagnostics8. Functionalized graphene-based materials for bioimaging applications9. Multifunctional magnetic nanoparticles for theranostic applications10. Stimuli-sensitive grafting polymers for targeted anticancer drug delivery 11. Functional moieties for intracellular traffic of nanomaterials12. Biofunctionalized mesoporous silica nanomaterials for nuclei targeting13. Lipid-derived nanoparticles for targeted delivery of siRNA14. Aptamer-siRNA nanoparticles for targeted anti-HIV therapeutics15. Peptide and protein self-assembled nanofibers for vaccine development and immunotherapy16. Functional biomaterials for vascular tissue engineering17. Functionalized hydrogels for culture and delivery of cellsPart III. Manufacturing, regulatory challenges and clinical testing of functionalized nanomaterial-based products18. Manufacturing and safety guidelines for the manufactured functional nanomaterials19. Challenges for planning clinical trials of functionalized nanomaterials20. Clinical testing of ACCURINS® therapeutics: challenges and lessons learned

BBruno Sarmento is Principal Investigator and Group Leader at Institute for Research and Innovation in Health (i3S), University of Porto (UP), and Invited Associate Professor at Instituto Universitário de Ciências da Saúde (IUCS), Portugal. His research is focused on the development of mucosal tissue engineering models to validate functionalized nanomedicines and to perform in vitro/in vivo correlation. He has also established functionalized nanomedicines for mucosal drug delivery of drug with poor mucosal bioavailability. He published more than 400 papers in international journals, most in top journals (20000 Scopus citations; H-index 73). He edited 5 books, participated in more than 50 invited/selected talks in national and international meetings and was awarded several distinctions. He has supervised/co-supervised 15 Post-Docs, 50 PhD students and 40 MSc students. He is editor of European Journal of Pharmaceutical Sciences, and member of the Editorial Advisory Board of several international journals, including the Journal of Controlled Release, Expert Opinion on Drug Delivery and Pharmaceutics. Bruno Sarmento was the first Chair of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society (CRS) and is now Director-at-Large of CRS and member of CRS College of Fellows. José das Neves is a Post-Doctoral Researcher at INEB, the Instituto de Engenharia Biomédica, Porto, Portugal. His research interests focuses on vaginal drug delivery, nanotechnology-based drug carriers and biomaterials. He has previously written 7 book chapters and is the co-editor of three books.

• Introduction: From the "magic bullet" to advanced nanomaterials: An historical perspective Part I. Ligand selection and functionalization of nanomaterials1. Phage display technology for screening antibody fragments2. Bioengineered approaches for site-orientation of peptide-based ligands of nanomaterials3. Engineered protein variants for bioconjugation4. Engineering of nanozymes for biomedical applications5. Strategies for the functionalization of mesoporous nanomaterials for biomedical use6. Systematic evolution of ligands by exponential enrichment (SELEX) for aptamer selection7. Biological methodologies for assessment of functionality of nanomaterialsPart II. Specific applications of functionalized nanomaterials in therapy and diagnostics8. Functionalized graphene-based materials for bioimaging applications9. Multifunctional magnetic nanoparticles for theranostic applications10. Stimuli-sensitive grafting polymers for targeted anticancer drug delivery 11. Functional moieties for intracellular traffic of nanomaterials12. Biofunctionalized mesoporous silica nanomaterials for nuclei targeting13. Lipid-derived nanoparticles for targeted delivery of siRNA14. Aptamer-siRNA nanoparticles for targeted anti-HIV therapeutics15. Peptide and protein self-assembled nanofibers for vaccine development and immunotherapy16. Functional biomaterials for vascular tissue engineering17. Functionalized hydrogels for culture and delivery of cellsPart III. Manufacturing, regulatory challenges and clinical testing of functionalized nanomaterial-based products18. Manufacturing and safety guidelines for the manufactured functional nanomaterials19. Challenges for planning clinical trials of functionalized nanomaterials20. Clinical testing of ACCURINS® therapeutics: challenges and lessons learned